The case for reactive mass oral cholera vaccinations

Reyburn, R; Deen, J L; Grais, R; Bhattacharya, S K; Sur, D; Lopez, A L; Jiddawi, M S; Clemens, J D; von Seidlein, L

dc.contributor.author	Reyburn, R
dc.contributor.author	Deen, J L
dc.contributor.author	Grais, R
dc.contributor.author	Bhattacharya, S K
dc.contributor.author	Sur, D
dc.contributor.author	Lopez, A L
dc.contributor.author	Jiddawi, M S
dc.contributor.author	Clemens, J D
dc.contributor.author	von Seidlein, L
dc.date.accessioned	2011-05-23T19:35:26Z
dc.date.available	2011-05-23T19:35:26Z
dc.date.issued	2011-01-25
dc.date.submitted	2011-04-29
dc.identifier.citation	PLoS Negl Trop Dis 2011;5(1):e952	en
dc.identifier.issn	1935-2735
dc.identifier.pmid	21283614
dc.identifier.doi	10.1371/journal.pntd.0000952
dc.identifier.uri	http://hdl.handle.net/10144/129950
dc.description.abstract	The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.
dc.language.iso	en	en
dc.relation.url	http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000952	en
dc.rights	Archived with thanks to PLoS Neglected Tropical Diseases and its Open Access policy.	en
dc.subject.mesh	Adolescent	en
dc.subject.mesh	Adult	en
dc.subject.mesh	Aged	en
dc.subject.mesh	Aged, 80 and over	en
dc.subject.mesh	Child	en
dc.subject.mesh	Child, Preschool	en
dc.subject.mesh	Cholera	en
dc.subject.mesh	Cholera Vaccines	en
dc.subject.mesh	Computer Simulation	en
dc.subject.mesh	Disease Outbreaks	en
dc.subject.mesh	Female	en
dc.subject.mesh	Humans	en
dc.subject.mesh	India	en
dc.subject.mesh	Infant	en
dc.subject.mesh	Infant, Newborn	en
dc.subject.mesh	Male	en
dc.subject.mesh	Mass Vaccination	en
dc.subject.mesh	Middle Aged	en
dc.subject.mesh	Models, Statistical	en
dc.subject.mesh	Tanzania	en
dc.subject.mesh	Young Adult	en
dc.subject.mesh	Zimbabwe	en
dc.title	The case for reactive mass oral cholera vaccinations	en
dc.type	Article	en
dc.contributor.department	International Vaccine Institute (IVI), Seoul, Korea; Epicentre, Paris, France; NICED, Kolkata, India; Ministry of Health and Social Welfare, Zanzibar, Tanzania; Menzies School of Health Research, Casuarina, Australia	en
dc.identifier.journal	PLoS Neglected Tropical Diseases	en
refterms.dateFOA	2019-03-04T08:44:52Z
html.description.abstract	The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.